Disparities in access to Dolutegravir in West African children, adolescents and young adults aged 0-24 years living with HIV.

Disparities in access to Dolutegravir in West African children, adolescents and young adults aged 0-24 years living with HIV.

Desmonde S, Dame J, Malateste K, et al. A IeDEA Pediatric West African cohort analysis. medRxiv [Preprint]. June 2024.